|
Volumn , Issue 43, 2016, Pages 91-108
|
Clinical Relevance of Prognostic and Predictive Molecular Markers in Gliomas
a |
Author keywords
ATRX; BRAF; Chromosomal deletion; EGFR; High grade glioma; IDH mutation; Low grade glioma; MGMT; Molecular markers; Predictive markers; Prognostic markers
|
Indexed keywords
ATRX PROTEIN, HUMAN;
DNA HELICASE;
DNA LIGASE;
DNA METHYLTRANSFERASE;
EGFR PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GENETIC MARKER;
IDH1 PROTEIN, HUMAN;
ISOCITRATE DEHYDROGENASE;
ISOCITRATE DEHYDROGENASE 2, HUMAN;
MGMT PROTEIN, HUMAN;
NUCLEAR PROTEIN;
TUMOR MARKER;
TUMOR SUPPRESSOR PROTEIN;
BRAIN;
BRAIN NEOPLASMS;
CANCER GRADING;
CHROMOSOME 1;
CHROMOSOME 19;
DNA METHYLATION;
GENETIC MARKER;
GENETICS;
GLIOBLASTOMA;
HUMAN;
NUCLEOTIDE SEQUENCE;
PATHOLOGY;
PROGNOSIS;
PROMOTER REGION;
BIOMARKERS, TUMOR;
BRAIN;
BRAIN NEOPLASMS;
CHROMOSOMES, HUMAN, PAIR 1;
CHROMOSOMES, HUMAN, PAIR 19;
DNA HELICASES;
DNA METHYLATION;
DNA MODIFICATION METHYLASES;
DNA MUTATIONAL ANALYSIS;
DNA REPAIR ENZYMES;
GENETIC MARKERS;
GLIOBLASTOMA;
HUMANS;
ISOCITRATE DEHYDROGENASE;
NEOPLASM GRADING;
NUCLEAR PROTEINS;
PROGNOSIS;
PROMOTER REGIONS, GENETIC;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 84965136656
PISSN: 00954829
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-319-21359-0_4 Document Type: Review |
Times cited : (41)
|
References (0)
|